With more than 100 investigational new drug applications (INDs) filed last year for gene-therapy products and multiple CAR T programs underway, consistent and reliable production of these therapies is needed to get treatments to patients.
Mustang Bio has built an industry-leading and proprietary CAR T manufacturing process and facility in Worcester, Mass capable of processing therapies with unrivaled quality for both clinical development and commercialization.
Features of this facility include:
- Central location in biotech park
- Fully equipped QC lab
- Full research and PD lab
- 4 separate cleanrooms
The new Mustang Advanced Research Site (MARS) facility
The facility also has an R&D center to develop new improvements in the manufacturing process to ensure that a high-quality and safe product gets to each and every patient.
To learn more about our manufacturing capabilities, or to inquire about utilizing Mustang Bio for your production needs, contact info@www.mustangbio.com.